First annual meeting of the Understanding (tumour-host interactions) Cluster held in Barcelona
On 31 January 2025, partners from across the Understanding (tumour-host Interactions) Cluster (U-THI-Clust) gathered in Barcelona, Spain, for the first annual cluster meeting, organised by the THRIVE project at the Centre Esther Koplowitz (IDIBAPS). The meeting brought together representatives from the six cluster projects, namely ARTURO, GLIOMATCH, HIT-GLIO, MULTIR, SPACETIME and THRIVE, alongside the Project Officer from HaDEA.
GLIOMATCH 3rd consortium meeting takes place in Düsseldorf, Germany
From 25 to 27 March 2025, the GLIOMATCH consortium convened in Düsseldorf, Germany, for its third consortium meeting. The meeting was held in-person and hosted by the partner University of Düsseldorf (UDUS). Over 40 experts from across Europe gathered to assess progress of the past year and plan the next phase of the GLIOMATCH project.
GLIOMATCH project kick-off meeting takes place in Leuven, Belgium
The GLIOMATCH project kick-off meeting took place from 25-27 March 2024 and was hosted by KU Leuven, the project coordinator, at the Faculty Club in Leuven, Belgium. This marks the first in-person gathering of the project’s 14 partner institutions.
GLIOMATCH: Pioneering personalised therapies for malignant glioma, a devastating brain cancer
According to the World Health Organisation, cancer ranks as the world’s second-leading cause of death. Brain tumours have particularly high mortality rates. The GLIOMATCH project is set to rewrite this narrative.
The GLIOMATCH project has officially started in January 2024
Under the coordination of KU Leuven, the multidisciplinary consortium will be working on pioneering personalised therapies for brain cancer patients.
GLIOMATCH selected for Horizon Europe funding
The GLIOMATCH project aimed at advancing precision medicine for brain cancer patients has received a total funding of €12.59 million from the EU, Switzerland, and the UK.